Population
Seminal plasma and purified Prostate-specific antigen (PSA)
Design
Preclinical
Authors
Loading...
PSA-IGFBP-3 cleavage may alter IGF-I bioavailability in semen; leaves open relevance to prostate cancer or fertility.
PSA acts as an IGFBP-3 protease in seminal plasma, potentially modulating IGF function in the reproductive system or prostate cancer.
Cohen et al. (1992) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: